Vanta Bioscience Ltd Half Yearly Results

Gross Sales

3.55

6.18

3.45

2.82

4.31

Excise Duty

0

0

0

0

0

Net Sales

3.55

6.18

3.45

2.82

4.31

Other Operating Income

0

0

0

0

0

Other Income

0.08

0.03

0.68

0.01

0.4

Total Income

3.62

6.21

4.13

2.83

4.71

Total Expenditure

4.3

4.11

5.3

3.37

2.33

PBIDT

-0.68

2.09

-1.17

-0.54

2.38

Interest

2.9

2.85

3.4

2.48

1.2

PBDT

-3.57

-0.76

-4.57

-3.02

1.18

Depreciation

2.95

1.54

1.36

1.31

0.66

Minority Interest Before NP

-4.55

-1.74

-2.1

-1.86

0.38

Tax

-0.04

0.04

0

0

0.04

Deferred Tax

-0.16

-0.06

0.09

0.09

0.03

Reported Profit After Tax

-1.78

-0.54

-3.92

-2.56

0.07

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-1.78

-0.54

-3.92

-2.56

0.07

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-1.78

-0.54

-3.92

-2.56

0.07

EPS (Unit Curr.)

-2.82

0.85

-6.21

-4.06

0.11

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

6.31

6.31

6.31

6.31

6.31

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-19.15

33.81

-33.91

-19.14

55.22

PBDTM(%)

-

-

-

-

-

PATM(%)

-50.14

-8.73

-113.62

-90.78

1.62